Drug Firm Lupin received USFDA approval to market HIV drug Prezista tablets
The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.
Drug firm Lupin on 30 December 2014 received the approval from the United States Food and Drugs Administration (USFDA) to market its generic drug Prezista tablets in the US. The tablets with chemical name Darunavir Ethanolate will be used to treat HIV-1 infection.
Earlier, the company had also received USFDA approval to market a generic version of ViiV Healthcare’s Epivir Tablets, used in treating HIV infection, in the American market.
The company is headquartered in Mumbai, India. Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations for the developed and developing markets of the world.